It is a measurable way of looking at the damage done from not getting the HIV BLA done. It is fortunate that there is a lot of other indications but if we were still pinning our hopes solely on HIV, we would be in real big trouble. This is why it should be sinking in for all of us just how damaging the RTF details from the Amarex screw up is. If they had within a year of the trial completion filed a complete BLA, we would have had an FDA approved drug on the market before Covid hit.

Think about how much faster enrollments would be, our access to funds as a revenue company and the ability to be uplisted to a real market. This Amarex screw up is very bad. I can only assume there was a significant regime change when Amarex was bought out because it is obvious everything took a nose dive in quality.